These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16586549)

  • 21. Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.
    Hua D; Huang ZH; Mao Y; Deng JZ
    World J Gastroenterol; 2007 Oct; 13(37):5030-4. PubMed ID: 17854149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy.
    Brücher BL; Keller G; Werner M; Müller U; Lassmann S; Cabras AD; Fend F; Busch R; Stein H; Allescher HD; Molls M; Siewert JR; Höfler H; Specht K
    Int J Colorectal Dis; 2009 Jan; 24(1):69-77. PubMed ID: 18704459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
    Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
    World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.
    Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Mori R; Ogawa R; Katada T; Fujii Y
    Dis Esophagus; 2008; 21(1):15-20. PubMed ID: 18197934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.
    Napieralski R; Ott K; Kremer M; Specht K; Vogelsang H; Becker K; Müller M; Lordick F; Fink U; Rüdiger Siewert J; Höfler H; Keller G
    Clin Cancer Res; 2005 Apr; 11(8):3025-31. PubMed ID: 15837757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of antisurvivin oligodeoxynucleotides on proliferation and apoptosis in gastric cancer cell line BGC-823 and the molecular mechanism].
    Li Y; Fan LQ; Sun Y; Zhao Q; Tan BB; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):265-9. PubMed ID: 21575496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
    Fakhrejahani E; Miyamoto A; Tanigawa N
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells.
    Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
    Acta Pharmacol Sin; 2006 Dec; 27(12):1630-6. PubMed ID: 17112419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.
    Shen YM; Yang XC; Yang C; Shen JK
    World J Gastroenterol; 2008 Sep; 14(33):5176-85. PubMed ID: 18777594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transfection of thymidine phosphorylase cDNA with lentiviral vector enhances the anticancer effect of 5'-deoxy-5-fluorouridine on colorectal cancer cell lines HT29 and LS174T].
    Ye D; Wang Q; Zhang J; Liu Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):18-24. PubMed ID: 25877313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
    Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.
    Jiang L; Yang W; Bian W; Yang H; Wu X; Li Y; Feng W; Liu X
    Oncol Res; 2018 Dec; 27(1):19-27. PubMed ID: 29495973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].
    Wang J; Zhang ZZ; Zhou TY; Liu YQ; Li HX
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):566-72. PubMed ID: 19102931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.